The National Institute of Standards and Technology (NIST) has published a comprehensive genomic dataset derived from the pancreatic cancer cells of a 61-year-old patient who explicitly consented to public data sharing. Utilizing over a dozen advanced genome sequencing technologies, the dataset comprises several terabytes of genetic information. This availability represents the first openly consented cancer cell line genome, removing ethical barriers for research and aiding the development of somatic variant detection methods, personalized tumor analyses, and cancer genome assemblies. This resource is expected to accelerate pancreatic cancer research, diagnostics, and targeted therapeutic development.